Table 2

Comparison of the frequency of HLA-A alleles carried on HLA-B27+ haplotype between patients with familial spondyloarthropathy and the French control population*

HLA-A allelePatients haplotypes (n=81)Control haplotypes (n=196)p Value†OR (95% CI)
OR, odds ratio; CI, confidence interval.
*Except where otherwise indicated, values are the number (%) of haplotypes; †statistical comparisons were performed, using Fisher's exact test.
A1 1 (1.2)11 (5.6)0.190.2 (0.03 to 1.7)
A231 (38.3)61 (31.3)0.261.4 (0.8 to 2.4)
A3 8 (9.9)20 (10)11 (0.4 to 2.29)
A1112 (14.8)18 (9.4)0.21.7 (0.8 to 3.8)
A23 1 (1.2) 2 (1.2)11.2 (0.1 to 13.6)
A24 4 (4.9)24 (12.1)0.080.4 (0.1 to 1.1)
A25 3 (3.7) 1 (0.6)0.087.5 (0.8 to 73.2)
A26 1 (1.2)13 (6.5)0.070.2 (0.02 to 1.4)
A28 7 (8.6)11 (5.6)0.421.6 (0.6 to 4.3)
A29 2 (2.5) 4 (2.1)11.2 (0.2 to 6.8)
A30 0 (0) 8 (3.8)0.110.1 (0.01 to 2.4)
A31 2 (2.5) 6 (2.9)10.8 (0.2 to 4.1)
A32 7 (8.6)16 (8.3)11.1 (0.4 to 2.7)
A33 1 (1.2) 1 (0.6)0.52.4 (0.2 to 39.5)
A43 1 (1.2) 0 (0)0.297.3 (0.3 to 182)